Press releases | Finanzwire

Basculer en Français

8218	Companies
110328	Keywords
52251	Articles
60646	Press releases

Home
Press releases

PRESS RELEASE

published on 07/11/2024 at 07:30, 3 months 26 days ago

Gerresheimer Remains on Track in 1st Half Year 2024
Gerresheimer reports 1.7% revenue growth and 2.9% adjusted EBITDA increase in 1st half 2024, with Plastics & Devices division showing dynamic growth and improved margin

Revenue Growth Gerresheimer Adjusted EBITDA Increase Plastics & Devices Division Guidance Confirmed
PRESS RELEASE

published on 07/11/2024 at 07:30, 3 months 26 days ago

Inside Information / Other news releases
GenSight Biologics launches a newsletter for retail investors providing updates, news articles, conferences, and financial figures in French, available via subscription on the company's website

Subscription Retail Investors Newsletter French GenSight Biologics
PRESS RELEASE

published on 07/11/2024 at 07:29, 3 months 26 days ago

Fielmann Group grows HY1/2024 sales +12% over 2023, improves profitability
Fielmann Group reports 12% sales growth in HY1/2024, with improved profitability and outlook for Vision 2025. Digitalization and international expansion drive growth

Profitability Digitalization Fielmann Group HY1/2024 Sales Vision 2025
PRESS RELEASE

published on 07/11/2024 at 07:15, 3 months 26 days ago

Inside Information / Other news releases
Eurofins provides update to key stakeholders on actions responding to Muddy Waters' reports and plans for related party transactions. Additionally, the company addresses cash accounting and corporate governance

Corporate Governance Muddy Waters Related Party Transactions Stakeholders Eurofins
PRESS RELEASE

published on 07/11/2024 at 07:05, 3 months 26 days ago

Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business
Heidelberg Pharma AG reports positive preliminary efficacy data for HDP-101 in multiple myeloma clinical trial. Key events include AACR Meeting presentation & FDA Orphan Drug Designation

Clinical Trial HDP-101 Heidelberg Pharma AG AACR Meeting FDA Orphan Drug Designation
REGULATED PRESS RELEASE

published on 07/11/2024 at 07:01, 3 months 26 days ago

Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity
Biophytis obtains FDA approval to start phase 2 OBA study in obesity with BIO101 (20-hydroxyecdysone), focusing on muscle strength improvement. Study led by Prof. Marc-André Cornier to start mid-2024 in the USA

Biophytis FDA Approval Obesity Treatment BIO101 Phase 2 OBA Study
PRESS RELEASE

published on 07/11/2024 at 07:00, 3 months 26 days ago

Gerresheimer remains on track in 1st half year 2024
Gerresheimer remains on track with 1.7% revenue growth and 2.9% EBITDA increase in the 1st half of 2024. Plastics & Devices division shows good revenue growth and improved margin. Forecast for 2024 and 2025 confirmed

EBITDA Revenue Growth Forecast Gerresheimer 1st Half Year 2024
PRESS RELEASE

published on 07/11/2024 at 06:58, 3 months 26 days ago

DocMorris with accelerated and significant eRx growth in new customers, market share and revenue
DocMorris reports accelerated eRx growth in new customers, market share, and revenue, with significant progress in eRx business and expanding customer base

Revenue Market Share DocMorris ERx Growth CardLink
PRESS RELEASE

published on 07/11/2024 at 03:00, 3 months 27 days ago

Charting the Future of Nutrition: Mission Hill Foods Expands Research and Strengthens Market Presence in North America
Mission Hill Foods invests in advanced research, dev, & sustainable practices for consumer health, expanding its capabilities & initiatives in North America

North America Research Development Sustainable Practices Mission Hill Foods
PRESS RELEASE

published on 07/11/2024 at 01:55, 3 months 27 days ago

Organto Provides Bi-Weekly Update on Filing of 2023 Annual Financial Statements and Status of MCTO
Organto Foods Inc. provides update on management cease trade order for late filing of annual financial statements. Company and auditors working to complete filings

Business Update Management Cease Trade Order Annual Financial Statements Organto Foods Inc. Organic Products

Accesswire

Published on 11/07/2024 at 01:00, 3 hours 30 minutes ago

Hyundai Mobis Selects BlackBerry QNX to Power Next-Generation Digital Cockpit Platform
Published on 11/07/2024 at 00:30, 4 hours ago

NexGold and Signal Gold Complete Upsized Concurrent Financing for $18.5 million
Published on 11/06/2024 at 23:24, 5 hours 6 minutes ago

Ur-Energy Releases 2024 Q3 Results
Published on 11/06/2024 at 23:00, 5 hours 30 minutes ago

Stabilis Solutions Announces Third Quarter 2024 Results
Published on 11/06/2024 at 23:00, 5 hours 30 minutes ago

Cerrado Closes Transaction With Hochschild Subsidiary For Sale of Monte Do Carmo Gold Project

View all ACCESSWIRE

EQS Group

Published on 11/06/2024 at 23:39, 4 hours 51 minutes ago

aap informs about the actual status of the mandatory convertible bond 2023-2028
Published on 11/06/2024 at 22:05, 6 hours 25 minutes ago

Nyxoah Reports Third Quarter Financial and Operating Results
Published on 11/06/2024 at 20:45, 7 hours 45 minutes ago

Fifteenth acquisition in 2024: Mutares has signed an agreement to acquire Natura sp. z o.o. from Pelion S.A.
Published on 11/06/2024 at 20:00, 8 hours 30 minutes ago

NOTICE OF TATATU SHAREHOLDERS' MEETING SPA
Published on 11/06/2024 at 19:40, 8 hours 50 minutes ago

EQS-Adhoc: EDAG Engineering Group AG: Results Q3 2024 und revision of outlook for fiscal year 2024

Les Echos

Published on 11/06/2024 at 18:03, 10 hours 27 minutes ago

Aéroports de Paris SA - Voting rights as of 31 October 2024
Published on 11/06/2024 at 18:00, 10 hours 30 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of October 31, 2024
Published on 11/06/2024 at 17:45, 10 hours 45 minutes ago

Information concerning the total number of voting rights and shares 2024 10 31
Published on 11/06/2024 at 17:45, 10 hours 45 minutes ago

Infotel : 2025 financial information agenda.
Published on 11/06/2024 at 17:45, 10 hours 45 minutes ago

October 2024

View all LES ECHOS COMFI WIRE